Dexcom G7 CGM Covered by Medicare; T1D Off-Label Drug Use; Another Tepezza Lawsuit

(MedPage Today) -- Dexcom announced that its G7 continuous glucose monitoring (CGM) system is now available to all Medicare patients with diabetes who meet the eligibility criteria, following the system launch last week. Half of kids ages 5 and...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news